Fin Cascade

Prices as of 8 Oct 2026 close · Not investment advice

Vital Chemtech Limited

NSE: VITALSpecialty Chemicals

Share price

₹52.50

-0.70% close of 8 Oct 2026

Market cap ₹126 CrP/E 126.0

Business score

How strong the business is, in one number. The parts behind it are in Pro.

45

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹126 Cr

P/E ratio

126.0

P/B ratio

1.3

ROCE

3.2%

ROE

1.0%

Dividend yield

0.0%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹66.1552-week low ₹35.40

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Fewer than three years of filings — too early to judge growth.

Whether it grew faster than its sector

It grew 18.4% a year against a sector median of 10.2% — 8.2 percentage points faster.

Room to re-rate, or risk of de-rating

Too little price history yet to compare it with its own past.

Whether growth justifies the valuation

Its earnings are falling, so growth cannot justify the price.

Profit growthPrice per ₹1 profitPer 1% growth
Vital Chemtech Limited — this one-50%/yr126×—
Anupam Rasayan India Limited-2%/yr71.5×—
Vinati Organics Limited2%/yr25.0×₹12.5
Elantas Beck India Limited18%/yr61.5×₹3.4
Jubilant Ingrevia Limited-2%/yr31.3×—
Alkyl Amines Chemicals Limited-8%/yr40.6×—

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Specialty Chemicals), it ranks 67 of 73 on returns, 13 of 72 on growth, 54 of 73 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

No durable advantage shows in the numbers: it earns 3.2% on capital, ahead of 8% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

No — Over the last five years it made ₹4 crore of cash from the business but spent ₹110 crore on plant and equipment, ₹106 crore more than it made; the gap was from lenders and shareholders. But only about 20 of every 100 rupees of profit it reported over 5 years arrived as cash — the rest is tied up. Its cash comes back faster than it used to: it went from being waiting 59 days for its cash to waiting 41 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

6 of 9 checks clear · 67%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Announced 14 Aug 2026 · Consolidated · Unaudited

Revenue

₹51 Cr

Net profit

₹3 Cr

EPS

₹1.08

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹126 Cr
Prev close
₹52.50
52w High
₹69.4
52w Low
₹35.4
Enterprise value
₹187 Cr
Beta
0.5
Price CAGR 1y
-15.0%
Price CAGR 3y
-18.0%
Price CAGR 5y
—
Price CAGR 10y
—

Ratios

Return on assets
0.5%
PEG ratio
-1.0
P/E ratio
126.0
P/B ratio
1.3
EV / EBITDA
18.7
Industry P/E
32.7
ROCE
3.2%
ROCE 5y average
6.0%
ROE
1.0%
Debt / Equity
0.6
Interest coverage
1.7
Dividend yield
0.0%
ROE 3y average
2.0%
ROE last year
1.0%

Annual P&L

Annual revenue
₹126 Cr
Annual profit
₹1 Cr
Operating margin
8.0%
Net profit margin
0.8%
EBITDA margin
7.9%
Sales growth 3y
2.5%
Sales growth 5y
—
Profit growth 3y
-50.0%
Profit growth 5y
—
EPS
₹0.4
Sales growth TTM
-6.0%
Profit growth TTM
-75.0%
Dividend payout
0.0%

Quarter P&L

Sales latest quarter
₹51 Cr
Profit latest quarter
₹3 Cr
YoY quarterly sales growth
51.4%
YoY quarterly profit growth
164.3%
OPM latest quarter
11.9%

Balance Sheet

Book Value
₹41.3
Face Value
₹10.0
Total debt
₹62 Cr
Total cash
₹1 Cr
Borrowings
₹62 Cr
Reserves / Equity
3.1

Cash Flow

Operating cash flow
₹5 Cr
Free cash flow
-₹19 Cr
FCF yield
-17.5%
Net cash flow
₹0 Cr

Shareholding

Promoter holding
73.4%
FII holding
1.6%
DII holding
0.3%
Public holding
24.7%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Pidilite Inds.1,474.9056.71,50,2240.77883.528.24,551.621.331.0
Gujarat Fluoroch4,453.0079.248,9160.07219.021.41,588.024.09.6
Navin Fluo.Intl.8,435.0554.443,2840.18243.3107.71,045.144.121.0
Aether Industri.1,744.5096.523,1540.0062.828.0326.627.311.9
Deepak Nitrite1,583.7027.221,6010.46345.0207.52,577.636.411.4
Atul5,958.0022.117,5410.50253.992.01,848.025.014.9
Aarti Industries479.9533.317,4100.20155.0256.52,387.042.56.9
Vital Chemtech52.6048.11260.002.6164.351.251.53.2
Median351.0028.11,0450.2313.551.6174.426.013.7

Competes with: Aarti Industries Limited, Aether Industries Limited, Atul Limited, BASF India Limited, Deepak Nitrite Limited, Gujarat Fluorochemicals Limited, Navin Fluorine International Limited, Pidilite Industries

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemSep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales52586156504966353465273551
Expenses3231253145
Material Cost2841
Change in Inventories-2.76-3.06
Purchases of Stock-in-Trade00
Employee Cost2.172.97
Other Expenses3.774.32
Operating Profit2.852.531.353.986.09
OPM %1620159.983.80-3.487.408.137.497.285.051112
Other Income0.620.280.190.240.13
Exceptional items (within Other Income)00
Interest0.500.4711.221
Depreciation1.271.111.682.041.79
Profit before tax1.701.23-1.140.963.43
Tax %3121171325
Net Profit1.170.98-1.330.842.59
EPS in Rs0.490.41-0.560.351.08
Diluted EPS in Rs0.730.570.361.08

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales5811798134126
Expenses4610298123116
Material Cost104
Change in Inventories-6.76
Purchases of Stock-in-Trade0
Employee Cost7.10
Other Expenses12
Operating Profit121501110
OPM %20130.2088
Other Income00331
Exceptional items (within Other Income)0
Interest01123
Depreciation12356
Profit before tax1111-062
Tax %26302693451
Net Profit88-141
EPS in Rs123.36-0.541.660.43
Diluted EPS in Rs1.690.43
Dividend Payout %015-9200

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
—
5 years
—
3 years
3%
TTM
-6%

Compounded profit growth

10 years
—
5 years
—
3 years
-50%
TTM
-75%

Stock price CAGR

10 years
—
5 years
—
3 years
-18%
1 year
-15%

Return on equity

10 years
—
5 years
6%
3 years
2%
Last year
1%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital724242424
Reserves866607675
Borrowings3629266662
Other Liabilities3019274158
Minority Interest0.61
Total Liabilities81138137207219
Fixed Assets1725436858
CWIP0001543
Investments315351313
Other Assets619860111105
Total Assets81138137207219

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-13-81465
Cash from Investing Activity1-26-35-39-5
Cash from Financing Activity1858-9331
Net Cash Flow624-3000
Free Cash Flow-22-18-7-40-19

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days264120146106115
Inventory Days87576147120
Days Payable26565111115185
Cash Conversion Cycle87112963949
Working Capital Days59116785541
ROCE %15063

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemNov 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Jun 2026
Promoters737373737373737373
FIIs6.533.620.780.560.161.781.781.621.62
DIIs4.121.810.960.330.250.250.250.250.25
Public162125262625252525
No. of Shareholders2,2841,8792,2762,3202,4322,1422,0922,0232,098

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year -12.5% (₹60.00 → ₹52.50)Brick size ₹2.78 (fixed)Bricks 31
₹40.00₹60.00₹52.50Nov '25Jan '26Mar '26May '26Jul '26
Price moved up one brickPrice moved down one brickLast close ₹52.50 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

61.11inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

News

News and filings about Vital Chemtech Limited. Open one to see why it matters.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Uses as raw material

  • Liquid chlorine
  • Liquid oxygen
  • Molten sulphur
  • Packing materials
  • Yellow phosphorus

Sells to

  • Alchem International · Phosphorus derivatives for life sciences
  • Bhagiradha Chemicals & Industries Limited · Phosphorus chemicals for agrochemical / crop care manufacture
  • Colourtex Industries · Phosphorus chemicals for textile auxiliaries
  • DCM Shriram Limited · Phosphorus chemicals for specialty chemicals
  • Divi's Laboratories · Phosphorus derivatives (POCl3, PCl3, PPA) for pharmaceutical APIs and intermediates
  • Dorf Ketal Chemicals · Phosphorus chemicals for specialty chemicals
  • Gharda Chemicals Limited · Phosphorus chemicals for dyes, pigments and plastic additives
  • IPCA Laboratories Limited · Phosphorus derivatives for pharmaceutical APIs and intermediates
  • Oneiro Industries · Phosphorus derivatives for life sciences
  • Pidilite Industries · Phosphorus chemicals for dyes, pigments and plastic additives
  • Rossari Biotech Limited · Phosphorus chemicals (P2O5, PPA) for textile auxiliaries
  • Sajjan India Limited · Phosphorus chemicals for agrochemical / crop care manufacture
  • Tagoor Laboratories Private Limited · Phosphorus derivatives for pharmaceutical intermediates
  • UPL Limited · Phosphorus chemicals (PCl3, POCl3) for agrochemical / crop care manufacture
  • Vasudha Pharma Chem Limited · Phosphorus derivatives for pharmaceutical APIs

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Specialty Chemicals
Classification
Chemicals › Specialty Chemicals
ISIN
INE0L4K01016

Plants

  • Dahej manufacturing facility · Dahej / Vagra, Bharuch, Gujarat

News impact

Big market events that reach Vital Chemtech Limited, and how the effect spreads.

No recent market events reach this company.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Splits, bonuses & buybacks

  • daily-prices repair: 14 rows from NSE's archive (replace 10, delete 0, insert 4), 2023-11-12..2026-03-02 (docs/flat_day_repair.md)1× · 12 Nov 2023

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.